The agreement on the joint development and production of innovative and foreign drugs

JSC "Chemical Diversity Research Institute" (CDRI) Group of the Center of High Technologies "KhimRar" (Khimki, Moscow region.) And St. Petersburg State Chemical-Pharmaceutical Academy (SPCPA) signed an agreement on cooperation in the development and manufacture of import substitution and innovative medicines.
The objectives of the agreement are defined in accordance with "The strategy of the pharmaceutical industry of the Russian Federation up to 2020".
The objectives of the Agreement:
• Development of innovative potential SPCPA.
• Attraction of budgetary and extra-budgetary investment and implementation of Government programs in the fields of pharmaceuticals and higher education.
• Increase the level of professional education in the preparation of master’s degrees, graduate degrees competitors — in accordance with the needs of the industry.
• Perform research and promotional work on contracts with companies producing and partner academic and research organizations.

CJSC "CDRI" Group of the Center of High Technologies "KhimRar"

Unique Biotechnology Center, performs research and development for major domestic and international pharmaceutical and agro-industrial companies.

St. Petersburg State Chemical-Pharmaceutical Academy (SPCPA)

Russia’s oldest institution of higher education, working in the field of pharmaceutical education. SPCPA figures in the development plans St. Petersburg pharmaceutical cluster as one of its basic research centers.

Like this post? Please share to your friends: